electroCore, Inc. (ECOR)
electroCore, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Rockaway, NJ, US. The stock last traded at $11.12, down 2.03% on the session, giving a market capitalisation of $100.3M. On trailing twelve-month figures it carries a trailing P/E of -6.54, a net margin of -40.0%. Its beta of 1.01 implies it has historically moved more than the broad market.
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
electroCore, Inc. is most often compared with the following Healthcare names: